Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions

被引：46
|
作者：
Schweighardt, B [1 ]
Ortiz, GM
Grant, RM
Wellons, M
Miralles, GD
Kostrikis, LG
Bartlett, JA
Nixon, DF
机构：
[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA
[2] Duke Univ, Med Ctr, Ctr AIDS Res, Durham, NC USA
[3] Trimeris Pharmaceut, Durham, NC USA
[4] Univ Athens, Sch Med, GR-11527 Athens, Greece
来源：
AIDS | 2002年 / 16卷 / 17期
关键词：
D O I：
10.1097/00002030-200211220-00018
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We report the emergence of drug-resistant viral mutations in chronically HIV-infected individuals undergoing structured treatment interruptions (STI). The protease mutation M46L and the reverse transcriptase mutations K101E and K103N were detected at the end of the second or third STI. We conclude that the repeated abrupt termination and resumption of certain antiretroviral drug regimens during STI therapy may lead to the development of drug resistance in chronically HIV-infected individuals.
引用
收藏
页码：2342 / 2344
页数：3
相关论文
共 50 条
  • [21] Source of HIV-1 drug-resistant minority variants in people who are recently infected
    Mbisa, J.
    Kirwan, P.
    Bibby, D.
    Brown, A.
    Myers, R.
    Murphy, G.
    Ledesma, J.
    Gill, O. N.
    Delpech, V.
    Asboe, D.
    Pozniak, A.
    Sabin, C.
    Dunn, D.
    Tostevin, A.
    Kirk, S.
    HIV MEDICINE, 2017, 18 : 6 - 6
  • [22] Epidemiology of drug-resistant HIV-1 transmission in naive patients in Spain
    Yebra, Gonzalo
    Holguin, Africa
    MEDICINA CLINICA, 2010, 135 (12): : 561 - 567
  • [23] A bibliometric analysis of HIV-1 drug-resistant minority variants from 1999 to 2024
    Chang Yan
    Fengting Yu
    Mengying Li
    Xiaojie Yang
    Rui Sun
    Xuelei Liang
    Xiaojie Lao
    Hanxi Zhang
    Wenhao Lv
    Ying Hu
    Yuan Lai
    Yi Ding
    Fujie Zhang
    AIDS Research and Therapy, 22 (1)
  • [24] Mechanisms of HIV-1 integrase resistance to dolutegravir and potent inhibition of drug-resistant variants
    Li, Min
    Passos, Dario Oliveira
    Shan, Zelin
    Smith, Steven J.
    Sun, Qinfang
    Biswas, Avik
    Choudhuri, Indrani
    Strutzenberg, Timothy S.
    Haldane, Allan
    Deng, Nanjie
    Li, Zhaoyang
    Zhao, Xue Zhi
    Briganti, Lorenzo
    Kvaratskhelia, Mamuka
    Burke Jr, Terrence R. R.
    Levy, Ronald M.
    Hughes, Stephen H.
    Craigie, Robert
    Lyumkis, Dmitry
    SCIENCE ADVANCES, 2023, 9 (29)
  • [25] Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters
    Balotta, C
    Corvasce, S
    Romano, L
    Violin, M
    Razzolini, F
    Vicenti, I
    Marconi, A
    Macchiesi, C
    Machetti, S
    Galli, A
    Duca, P
    Zazzi, M
    ANTIVIRAL THERAPY, 2004, 9 (04) : U52 - U52
  • [26] Emergence and Persistence of Minor Drug-Resistant HIV-1 Variants in Ugandan Women after Nevirapine Single-Dose Prophylaxis
    Hauser, Andrea
    Mugenyi, Kizito
    Kabasinguzi, Rose
    Kuecherer, Claudia
    Harms, Gundel
    Kunz, Andrea
    PLOS ONE, 2011, 6 (05):
  • [27] Minority Variants of Drug-Resistant HIV
    Gianella, Sara
    Richman, Douglas D.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (05): : 657 - 666
  • [28] Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV
    Ghosh, Arun K.
    Dawson, Zachary L.
    Mitsuya, Hiroaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (24) : 7576 - 7580
  • [29] Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure
    Paredes, Roger
    Lalama, Christina M.
    Ribaudo, Heather J.
    Schackman, Bruce R.
    Shikuma, Cecilia
    Giguel, Francoise
    Meyer, William A., III
    Johnson, Victoria A.
    Fiscus, Susan A.
    D'Aquila, Richard T.
    Gulick, Roy M.
    Kuritzkes, Daniel R.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (05): : 662 - 671
  • [30] Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan
    Gatanaga, Hiroyuki
    Ibe, Shiro
    Matsuda, Masakazu
    Yoshida, Shigeru
    Asagi, Tsukasa
    Kondo, Makiko
    Sadamasu, Kenji
    Tsukada, Hiroki
    Masakane, Aki
    Mori, Haruyo
    Takata, Noboru
    Minami, Rumi
    Tateyama, Masao
    Koike, Takao
    Itoh, Toshihiro
    Imai, Mitsunobu
    Nagashima, Mami
    Gejyo, Fumitake
    Ueda, Mikio
    Hamaguchi, Motohiro
    Kojima, Yoko
    Shirasaka, Takuma
    Kimura, Akiro
    Yamamoto, Masahiro
    Fujita, Jiro
    Oka, Shinichi
    Sugiura, Wataru
    ANTIVIRAL RESEARCH, 2007, 75 (01) : 75 - 82
12345